ClinicalTrials.govpublic full text
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
glioblastoma, idh-wildtype, mgmt-methylated glioblastoma, precision medicine, temozolomide, lomustine, ccnu, survival, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 883994
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.